Cargando…
Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer
Breast cancer is classified into four major molecular subtypes, and is considered a heterogenous disease. The risk profiles and treatment of breast cancer differ according to these subtypes. Early detection dramatically improves the prospects of successful treatment, resulting in a reduction in over...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951384/ https://www.ncbi.nlm.nih.gov/pubmed/35328602 http://dx.doi.org/10.3390/ijms23063181 |